| Literature DB >> 28391067 |
Flavia R Silva1, Artur S Miranda1, Rebeca P M Santos2, Isabella G Olmo1, Gerald W Zamponi3, Tomas Dobransky4, Jader S Cruz1, Luciene B Vieira5, Fabiola M Ribeiro6.
Abstract
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion in the amino-terminal region of the huntingtin (htt) protein. In addition to facilitating neurodegeneration, mutant htt is implicated in HD-related alterations of neurotransmission. Previous data showed that htt can modulate N-type voltage-gated Ca2+ channels (Cav2.2), which are essential for presynaptic neurotransmitter release. Thus, to elucidate the mechanism underlying mutant htt-mediated alterations in neurotransmission, we investigated how Cav2.2 is affected by full-length mutant htt expression in a mouse model of HD (BACHD). Our data indicate that young BACHD mice exhibit increased striatal glutamate release, which is reduced to wild type levels following Cav2.2 block. Cav2.2 Ca2+ current-density and plasma membrane expression are increased in BACHD mice, which could account for increased glutamate release. Moreover, mutant htt affects the interaction between Cav2.2 and 2 major channel regulators, namely syntaxin 1A and Gβγ protein. Notably, 12-month old BACHD mice exhibit decreased Cav2.2 cell surface expression and glutamate release, suggesting that Cav2.2 alterations vary according to disease stage.Entities:
Keywords: BACHD; G(βγ) subunits; Glutamate; Huntington's disease; N-type Ca(2+) channels; Syntaxin
Mesh:
Substances:
Year: 2017 PMID: 28391067 DOI: 10.1016/j.neurobiolaging.2017.03.015
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673